Canine leishmaniasis: epidemiological risk and the experimental model
- PMID: 12377257
- DOI: 10.1016/s1471-4922(02)02347-4
Canine leishmaniasis: epidemiological risk and the experimental model
Abstract
Increasing risk factors are making zoonotic visceral leishmaniasis a growing public health concern in many countries. Domestic dogs constitute the main reservoir of Leishmania infantum and Leishmania chagasi, and play a key role in the transmission to humans. New reagents and tools allow the detailed investigation of canine leishmaniasis, permitting the monitoring of the immunological status of dogs in both natural and experimental infections. Such studies are essential to determine the basis of the canine protective immune response and to establish a laboratory model, a significant aspect for the development of vaccines against canine leishmaniasis.
Similar articles
-
Immunity to Leishmania and the rational search for vaccines against canine leishmaniasis.Trends Parasitol. 2010 Jul;26(7):341-9. doi: 10.1016/j.pt.2010.04.005. Epub 2010 May 18. Trends Parasitol. 2010. PMID: 20488751 Review.
-
Heterologous prime-boost vaccination with a non-replicative vaccinia recombinant vector expressing LACK confers protection against canine visceral leishmaniasis with a predominant Th1-specific immune response.Vaccine. 2008 Jan 17;26(3):333-44. doi: 10.1016/j.vaccine.2007.11.021. Epub 2007 Nov 29. Vaccine. 2008. PMID: 18093705
-
Canine leishmaniasis.Adv Parasitol. 2004;57:1-88. doi: 10.1016/S0065-308X(04)57001-X. Adv Parasitol. 2004. PMID: 15504537 Review.
-
Immunology of canine leishmaniasis.Parasite Immunol. 2006 Jul;28(7):329-37. doi: 10.1111/j.1365-3024.2006.00840.x. Parasite Immunol. 2006. PMID: 16842269 Review.
-
Long-lasting protection against canine visceral leishmaniasis using the LiESAp-MDP vaccine in endemic areas of France: double-blind randomised efficacy field trial.Vaccine. 2007 May 22;25(21):4223-34. doi: 10.1016/j.vaccine.2007.02.083. Epub 2007 Mar 15. Vaccine. 2007. PMID: 17395339 Clinical Trial.
Cited by
-
Molecular fingerprinting of Leishmania infantum strains following an outbreak of visceral leishmaniasis in central Israel.J Clin Microbiol. 2005 Dec;43(12):6054-9. doi: 10.1128/JCM.43.12.6054-6059.2005. J Clin Microbiol. 2005. PMID: 16333098 Free PMC article.
-
Leishmania infection: laboratory diagnosing in the absence of a "gold standard".Am J Trop Med Hyg. 2010 Feb;82(2):251-6. doi: 10.4269/ajtmh.2010.09-0366. Am J Trop Med Hyg. 2010. PMID: 20134001 Free PMC article.
-
Prevalence and incidence of canine visceral leishmaniasis and its clinical-immunological features in an endemic area of the Brazilian Amazon.Vet Med Sci. 2023 Nov;9(6):2463-2474. doi: 10.1002/vms3.1218. Epub 2023 Aug 31. Vet Med Sci. 2023. PMID: 37654028 Free PMC article.
-
Clinical, Molecular and Serological Diagnosis of Canine Leishmaniosis: An Integrated Approach.Vet Sci. 2020 Apr 14;7(2):43. doi: 10.3390/vetsci7020043. Vet Sci. 2020. PMID: 32295198 Free PMC article.
-
The protective immune response produced in dogs after primary vaccination with the LiESP/QA-21 vaccine (CaniLeish®) remains effective against an experimental challenge one year later.Vet Res. 2014 Jun 25;45(1):69. doi: 10.1186/1297-9716-45-69. Vet Res. 2014. PMID: 24964736 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources